Cancer immunotherapy — stimulating the body’s disease-fighting immune system to wrestle cancer — is all the rage among companies and investors at this week’s J.P. Morgan Healthcare Conference.
But a few blocks away, at the American Society of Clinical Oncology’s Gastrointestinal Cancer Symposium at the Moscone Center, tiny Aduro BioTech Inc. is making news Tuesday with results from a mid-stage study in one of the toughest cancers to beat.
Help employers find you! Check out all the jobs and post your resume.
